Guidelines for case classification for the national birth defects prevention study

被引:513
作者
Rasmussen, SA
Olney, RS
Holmes, LB
Lin, AE
Keppler-Noreuil, KM
Moore, CA
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30341 USA
[2] Massachusetts Gen Hosp, Genet & Teratol Unit, Serv Pediat, Boston, MA 02114 USA
[3] Univ Iowa Hosp & Clin, Dept Pediat, Div Med Genet, Iowa City, IA 52242 USA
关键词
D O I
10.1002/bdra.10012
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
BACKGROUND: Previous studies have suggested that etiologic heterogeneity may complicate epidemiologic analyses designed to identify risk factors for birth defects. Case classification uses knowledge of embryologic and pathogenetic mechanisms to make case groups more homogeneous and is important to the success of birth defects studies. METHODS: The goal of the National Birth Defects Prevention Study (NBDPS), an ongoing multi-site case-control study, is to identify environmental and genetic risk factors for birth defects. Information on environmental risk factors is collected through an hour-long maternal interview, and DNA is collected from the infant and both parents for evaluation of genetic risk factors. Clinical data on infants are reviewed by clinical geneticists to ensure they meet the detailed case definitions developed specifically for the study. To standardize the methods of case classification for the study, an algorithm has been developed to guide NBDPS clinical geneticists in this process. RESULTS: Methods for case classification into isolated, multiple, and syndrome categories are described. Defects considered minor for the purposes of case classification are defined. Differences in the approach to case classification for studies of specific defects and of specific exposures are noted. CONCLUSIONS: The case classification schema developed for the NBDPS may be of value to other clinicians working on epidemiologic studies of birth defects etiology. Consideration of these guidelines will lead to more comparable case groups, an important element of careful studies aimed at identifying risk factors for birth defects. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:193 / 201
页数:9
相关论文
共 51 条
[1]   Teratogenic effects of antiepileptic drugs: Use of an international database on malformations and drug exposure (MADRE) [J].
Arpino, C ;
Brescianini, S ;
Robert, E ;
Castilla, EE ;
Cocchi, G ;
Cornel, MC ;
de Vigan, C ;
Lancaster, PAL ;
Merlob, P ;
Sumiyoshi, Y ;
Zampino, G ;
Renzi, C ;
Resano, A ;
Mastroiacovo, P .
EPILEPSIA, 2000, 41 (11) :1436-1443
[2]   CHARGE association: An update and review for the primary pediatrician [J].
Blake, KD ;
Davenport, SLH ;
Hall, BD ;
Hefner, MA ;
Pagon, RA ;
Williams, MS ;
Lin, AE ;
Graham, JM .
CLINICAL PEDIATRICS, 1998, 37 (03) :159-173
[3]  
Botto LD, 1996, PEDIATRICS, V98, P911
[4]   BIOCHEMICAL AND MOLECULAR TERATOLOGY OF FETAL HYDANTOIN SYNDROME [J].
BUEHLER, BA ;
RAO, V ;
FINNELL, RH .
NEUROLOGIC CLINICS, 1994, 12 (04) :741-748
[5]   Postmarketing surveillance for human teratogenicity: A model approach [J].
Chambers, CD ;
Braddock, SR ;
Briggs, GG ;
Einarson, A ;
Johnson, YR ;
Miller, RK ;
Polifka, JE ;
Robinson, LK ;
Stepanuk, K ;
Jones, KL .
TERATOLOGY, 2001, 64 (05) :252-261
[6]   Pathogenetic mechanisms of congenital cardiovascular malformations revisited [J].
Clark, EB .
SEMINARS IN PERINATOLOGY, 1996, 20 (06) :465-472
[7]  
Cohen Jr MM, 1997, CHILD MULTIPLE BIRTH
[8]   PATTERNS OF MALFORMATION IN CHILDREN WITH CONGENITAL DIAPHRAGMATIC DEFECTS [J].
CUNNIFF, C ;
JONES, KL ;
JONES, MC .
JOURNAL OF PEDIATRICS, 1990, 116 (02) :258-261
[9]  
Ferencz C, 1997, Genetic and Environmental Risk Factors of Major Cardiovascular Malformations: The Baltimore-Washington Infant Study-1981-1989
[10]  
Ferencz C., 1993, EPIDEMIOLOGY COGENIT, V4, P1